![Didier Hoch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Didier Hoch
Président chez
PHAXIAM THERAPEUTICS S.A.
Fortune : 107 157 $ au 31/05/2026
Profil
Didier Hoch is the founder of Big Booster'S (2014).
Current jobs include Co-Chairman at Underground Charity Foundation (2018), Chairman at PHAXIAM Therapeutics SA (2023), Director at Fondation Universite Grenoble Alpes, Director at Goliver Therapeutics, and Independent Member-Supervisory Board at Myasterix.
Former jobs include Chairman & Chief Executive Officer at Pherecydes Pharma SA (2022), Chairman at MSD Vaccines Ltd. (2010), Chairman at Sanofi Pasteur SA (2000-2010), Non-Executive Chairman at Pevion Biotech AG (2011-2013), Chairman at BioVision (2013-2018), Chairman at Fondation pour l’Université de Lyon (2014-2018), Chairman at OSE Immunotherapeutics SA (2024-2025), Director at DBV Technologies SA (2012-2016), Independent Director at ERYTech Pharma SA, Independent Director at Effimune SA, Independent Director at Germitec SA (2014-2019), Vice President at Rhone Poulenc Rorer (2000-2009), President at European Vaccine Manufacturers (2009-2010), Member-Supervisory Board at Genticel SA (2014-2017), President-Life Science Health Committee at Mouvement des Entreprises de France, and Vice President-Africa & Middle East Region at Aventis Pharma International SAS. Education includes an undergraduate degree from ESCP Europe Campus Paris and a doctorate from the University of Lyon (1984).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/09/2025 | 20 965 ( 0,09 % ) | 107 157 $ | 31/05/2026 |
Postes actifs de Didier Hoch
| Sociétés | Poste | Début |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Président | 23/06/2023 |
Goliver Therapeutics | Directeur/Membre du Conseil | - |
Fondation Universite Grenoble Alpes
 Fondation Universite Grenoble Alpes Miscellaneous Commercial ServicesCommercial Services Operates as a public research university | Directeur/Membre du Conseil | - |
Underground Charity Foundation | Président | 01/01/2018 |
Myasterix | Directeur/Membre du Conseil | - |
Anciens postes connus de Didier Hoch
| Sociétés | Poste | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Président | 30/09/2025 |
Germitec SA
 Germitec SA Medical SpecialtiesHealth Technology Manufactures UV-C disinfection devices | Directeur/Membre du Conseil | 01/01/2019 |
Fondation pour l’Université de Lyon | Président | 02/01/2018 |
BioVision | Président | 01/01/2018 |
| ░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Didier Hoch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products. | Process Industries |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and supplies vaccines | Health Technology |
ESCP Europe Campus Paris
 ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Health Technology |
Pevion Biotech AG
 Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
European Vaccine Manufacturers | |
University of Lyon
 University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genticel SA
 Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Health Technology |
Mouvement des Entreprises de France
 Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Operates network entrepreneurs | Commercial Services |
Effimune SA
 Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
Germitec SA
Germitec SA Medical SpecialtiesHealth Technology Manufactures UV-C disinfection devices | Health Technology |
BioVision | |
Myasterix | |
Fondation pour l’Université de Lyon | |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Aventis Pharma International SAS | |
Underground Charity Foundation | |
Fondation Universite Grenoble Alpes
Fondation Universite Grenoble Alpes Miscellaneous Commercial ServicesCommercial Services Operates as a public research university | Commercial Services |
Goliver Therapeutics | |
Big Booster'S
 Big Booster'S Miscellaneous Commercial ServicesCommercial Services Provides acceleration program services for digital, environment and healthcare | Commercial Services |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
